HomeNewsBusinessStartupDigital transactions recover in May after initial COVID-induced fall

Digital transactions recover in May after initial COVID-induced fall

The cumulative value of transactions fall by 25 percent in January-May 2020, compared to the same period in 2019. RuPay card transactions through online portals grow by 237 percent in April 2020 from February.

August 25, 2020 / 18:39 IST
Story continues below Advertisement
Representative Image (REUTERS/Danish Siddiqui)
Representative Image (REUTERS/Danish Siddiqui)

COVID-19 has caused the cumulative value of digital transactions between January and May 2020 to fall by 25 percent year-on-year (YoY). During the same five months last year, transactions had jumped 20 percent YoY, the Reserve Bank of India (RBI) said in its Annual Report for 2019-20.

It cited the COVID-induced economic slowdown as one reason for the fall. At the same time, the rate of increase of currency with the public has been accelerating.

Story continues below Advertisement

While the first few months showed a drastic fall in digital payments, May showed some recovery, said the central bank. Online commerce continued to drive volumes. The share of RuPay card usage for online payments versus face-to-face merchant transactions jumped to 237 percent in April, compared to 76 percent in February. This showed that consumers preferred to shop online over visiting shops or malls for shopping.

The central bank has used these data points to show that the trends on digital transactions are indicative of the overall economic health of the country.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show